Precision Biologics
Precision Biologics develops antibody therapies and diagnostics that target cancer cells. Its pipeline includes investigational monoclonal antibodies, antibody-drug conjugates and cellular therapies. Established in 2012, the company builds on cancer immunotherapy research led by Dr. Myron Arlen.
Key facts
| Company Operating Status | Active |
|---|---|
| Full Address | 4922 Fairmont Avenue, Suite 320, Bethesda, MD 20814 |
| Wellfound ID | precision-biologics |
Contact details
Email and phone for Precision Biologics are available to signed-in members of CliffBio.
Sign in to view